Alx Oncology Holdings Inc
ALXO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810182
In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 3 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Alx Oncology Holdings Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- +3 vs. Q1 2022
- Shares held
- 35.9M
- −838.2K (−2.3%) vs. Q1 2022
- Total value
- $290.7M
- −$330.8M (−53.2%) vs. Q1 2022
- New holders
- 18
- 36 more added
- Sold out
- 15
- 23 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALXO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 93 | $217.9M |
| Q1 2026 | 69 | $189.0M |
| Q4 2025 | 57 | $33.0M |
| Q3 2025 | 61 | $50.8M |
| Q2 2025 | 61 | $12.1M |
| Q1 2025 | 85 | $21.7M |
| Q4 2024 | 87 | $68.5M |
| Q3 2024 | 92 | $82.7M |
| Q2 2024 | 112 | $293.4M |
| Q1 2024 | 106 | $510.5M |
| Q4 2023 | 93 | $681.5M |
| Q3 2023 | 76 | $159.8M |
| Q2 2023 | 75 | $257.5M |
| Q1 2023 | 86 | $161.4M |
| Q4 2022 | 87 | $410.6M |
| Q3 2022 | 99 | $348.7M |
| Q2 2022 | 97 | $290.7M |
| Q1 2022 | 96 | $621.9M |
| Q4 2021 | 108 | $780.0M |
| Q3 2021 | 115 | $2.55B |
| Q2 2021 | 105 | $1.82B |
| Q1 2021 | 94 | $2.47B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Alx Oncology Holdings Inc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 0 | $0 | 0.00% | −86,072−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −50,123−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −14,257−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −13,189−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −10,745−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −10,150−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,242−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −577−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −303−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −130−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −68−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| IndexIQ Advisors LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |